|
Recent Developments |
|
07-AUG-10
Sterling Biotech has posted a net profit of Rs 447.04 million for the quarter ended Jun. 30, 2010 as compared to Rs 404.74 million for the same quarter a year ago, rise of 10.45%.
Future Plans
The company plans to borrow funds by way of secured/collateral loans, bonds, securities or other instruments having an aggregate value of about Rs. 15 billion to finance the assets as well as working capital requirements from time to time.
... More.. |
| Business Profile |
Future Plans |
|
|
|
One To One
| Face To Face | | Sterling Biotech Ltd, the largest manufacturer of gelatin has undertaken expansion of Rs 236 crores. The gelatin demand in domestic market to grow by 15 per cent while globally the growth to be around 3 per cent. Nitin Sandesara,Chairman |
|
|
Recent news
|
|
|
| Period ending (months) | 31-Mar-2019 (12) | 31-Dec-2015(12) | 31-Dec-2014 (12) | | Net sales | 3495.34 | 4120.56 | 6669.51 | | Other Income | 23.30 | 0.00 | 0.00 | | Total Income | 3518.64 | 4120.56 | 6669.51 | | Cost of goods sold | -8101.07 | 5008.54 | 5557.13 | | OPBDIT | 11619.71 | -887.98 | 1112.38 | | PAT | -33302.57 | -3768.49 | -4577.05 | | Gross Block | - | - | - | | Equity capital | 0.00 | 272.05 | 272.05 | | EPS (Rs.) | 0.00 | - | -16.82 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | NA | - | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 330.2 | -21.5 | 16.7 | | Net margin (% of OI) | -946.5 | -91.5 | -68.6 |
|
|
Detailed Financials
|
|
|
|
|
